SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Thursday 12 November 2026
News from the 24 hours to Thursday morning, 12 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage was mainly about the start of the second half of the company's $500 million share buyback, which is mildly positive. This was offset by commentary on a weaker outlook and the end of talks with Johnson & Johnson.
What drove it
- share buyback
- weaker outlook
- J&J talks ended
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Fri 6 Nov | −6.8 | 5 |
| Sat 7 Nov | −5.3 | 2 |
| Mon 9 Nov | +0.8 | 1 |
| Tue 10 Nov | −5.0 | 1 |
| Thu 12 Nov | +0.8 | 5 |
| Fri 13 Nov | −5.7 | 3 |
3 stories · 5 headlines · strongest first
Pharma and healthcare on 12 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Smith & Nephew begins second $250m phase of its buyback +3.93 headlines today · Smith & Nephew began the second half of its $500m buyback, using Merrill Lynch. | ||
| +4.2 | Company begins latter half of its share repurchase, returning capital to holders. | |
| +4.0 | Second portion of repurchase programme begins, signalling confidence in capital returns. | |
| +3.7 | Company appoints a bank to carry out part of its repurchase plan. | |
| Smith & Nephew lowers 2026 guidance and ends talks with J&J −4.51 headline today · 23 in all, since 9 October · A piece asks if Smith & Nephew still seeks a deal after lower outlook and ended J&J talks. | ||
| −6.3 | Weaker guidance and ended takeover discussions leave strategic direction uncertain. | |
| Smith & Nephew market watch commentary +0.51 headline today · An article considers which factors the market ought to monitor at Smith & Nephew. | ||
| +0.5 | General preview of items investors might follow; no clear direction. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.